Today's wonder is CRISPR - Cas9, which allows for genome editing and has potential for extraordinary scientific and biomedical initiatives to treat human genetic disease. AstraZeneca last month announced collaborations to use the technology to identify and validate new drug targets.
The video is from the McGovern Institute for Brain Research at MIT (a fascinating site), where Feng Zhang is an investigative researcher at MIT-Harvard Broad Institute and a leader in the technology's development. (See the article below about the controversy over CRISPR's patent.)
Antonio Regalado, "Who Owns the Biggest Biotechnology Discovery of the Century?", MIT Technology Review, December 4, 2015
(My thanks to 3 Quarks Daily for the link.)